SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615219-16-000218
Filing Date
2016-08-03
Accepted
2016-08-03 16:54:07
Documents
58
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flks201663010-q.htm 10-Q 690667
2 EXHIBIT 10.1 flks2016630ex-101.htm EX-10.1 117945
3 EXHIBIT 10.2 flks2016630ex-102.htm EX-10.2 80509
4 EXHIBIT 31.1 flks2016630ex-311.htm EX-31.1 10234
5 EXHIBIT 31.2 flks2016630ex-312.htm EX-31.2 10284
6 EXHIBIT 32.1 flks2016630ex-321.htm EX-32.1 9395
13 a20160509trilogysuppl_image1.gif GRAPHIC 18603
  Complete submission text file 0001615219-16-000218.txt   4084877

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT flks-20160630.xml EX-101.INS 771141
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20160630.xsd EX-101.SCH 25726
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20160630_cal.xml EX-101.CAL 51176
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20160630_def.xml EX-101.DEF 109158
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20160630_lab.xml EX-101.LAB 408140
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20160630_pre.xml EX-101.PRE 233239
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36812 | Film No.: 161804568
SIC: 2834 Pharmaceutical Preparations